Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid

Published:2013-08-05 Issue:7 Volume:38 Page:794-803
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Boberg K. M.,Wisløff T.¹,Kjøllesdal K. S.²,Støvring H.³,Kristiansen I. S.⁴

Affiliation:

1. Norwegian Knowledge Centre for the Health Services; Oslo; Norway

2. Oslo Hospital Service; Oslo University Hospital; Oslo; Norway

3. Department of Public Health; Aarhus University; Aarhus; Denmark

4. Department of Health Management and Health Economics; Institute of Health and Society; University of Oslo; Oslo; Norway

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12435/fullpdf

Reference28 articles.

1. Primary biliary cirrhosis;Kaplan;N Engl J Med,1996

2. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years;Prince;Gastroenterology,2002

3. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis;Heathcote;Hepatology,1994

4. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis;Lindor;Gastroenterology,1994

5. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver;Pares;J Hepatol,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics-based study of possible genetic mechanisms and potential therapeutic agents for PBC;2022-11-23

2. Danaparoid Sodium: A Review of Its Use in Hepatic Thrombotic Disorders;Anticoagulation - Current Perspectives;2022-06-15

3. Emerging drugs for the treatment of primary biliary cholangitis;Expert Opinion on Emerging Drugs;2020-04-02

4. Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis;Journal of Clinical Gastroenterology;2019-10

5. Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States;Hepatology Communications;2019-01-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3